Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John W. Babich currently holds 185,906 shares of Molecular Insight Pharmaceuticals, Inc. (MIPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John W. Babich has been a net buyer of MIPI stock. They have purchased $89.5K and sold $0 worth of shares.
John W. Babich's most recent insider trade was on May 20, 2008, when they sold 30,000 shares at $0.00 per share.
John W. Babich serves as Executive at Molecular Insight Pharmaceuticals, Inc. (MIPI). They have executed 9 insider transactions totaling $89.5K over their tenure at the company.
John W. Babich holds the position of Executive at Molecular Insight Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
John W. Babich has shown a buying trading pattern, with $89.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by John W. Babich was on Feb 28, 2007, when they sold $48.0K worth of MIPI shares. This transaction involved 80,000 shares at $0.60 per share.
John W. Babich currently owns 185,906 shares of Molecular Insight Pharmaceuticals, Inc. (MIPI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John W. Babich's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John W. Babich has 9 Form 4 filings on record as an insider at Molecular Insight Pharmaceuticals, Inc..
Set alerts for John W. Babich and 40,000+ other insiders.